EGYPT – Dr. Mohamed Galal, Vice President & Head of Bayer Consumer Health Division – Middle East, and Mr. Ayman Hossam Omar, Chief Executive Officer of United Company for Trading & Distribution (UCTD), have signed a contract involving Bayer’s Consumer Health Division, aiming to import and distribute OTC products in the Egyptian market.
Over-the-counter (OTC) medicines play an essential role in keeping consumers and populations healthy with a variety of options while, at the same time driving down healthcare spending.
“We envision this valuable partnership between the two big companies in the medical manufacturing field (Bayer) and, the distribution field (UCTD) to provide a multitude of benefits to the market and the Egyptian consumers simultaneously,” Ayman Hossam said.
The inclusion of Bayer Consumer health over-the-counter medications will be available too, ensuring its supply to all communities and entities that rely on expertise and capabilities to meet consumers’ needs and ease their wellbeing.
This collaborative partnership marks a new strategic alliance with promising prospects and high added value for consumers.
The most notable benefit is the availability of Bayer essential products like Becozyme, Bepanthen, Redoxon, Elivit, Rennie, and Clarinase. All these products will always be available and accessible at a huge number of pharmacies in Egypt.
These medications will also infiltrate cities and all governorates via the largest distribution network in Egypt, comprised of more than 80 branches in more than 60,000 pharmacies.
“At Bayer’s Consumer Health division, our vision is to make self-care for a better life a reality for billions of people around the world through everyday healthcare. Self-care has never been more important in helping people achieve better health and enabling healthcare systems worldwide to become more sustainable.
By providing access to informative tools, resources and knowledge on how to improve people’s daily health – from choosing healthy lifestyles and using consumer products effectively to proper information and self-care learning tools to support appropriate self-diagnosis and self-treatment – we are making a positive impact on the lives of individuals and society as a whole”, added Mohamed Galal.